Watch Ticker

Bristol-Myers Squibb Co.

Go to Bristol-Myers Squibb Co. Website

$44.32

1.01 (2.33%)

Live

Previous Close

$44.23

Day Range

$43.57 - $44.455

Previous Day Range

$42.96 - $45.51

Market Cap

$90.0 billion USD

Day Vol.

18.6 million

Previous Day Vol.

44.5 million

Currency

USD

Primary Exchange

New York Stock Exchange

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol deriv...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Researchandmarkets.Com - Testicular Cancer Market Analysis and Forecast Report 2025-2035 | Emerging Trends Highlight Shift Towards Immunotherapy in Testicular Cancer

Global testicular cancer market is evolving with emerging trends in personalized therapies, immunotherapy, and fertility preservation, driven by key pharmaceutical companies focusing on innovative treatment approaches.

Related tickers: PFE, MRK, RHHBY, BMY, CELGr, LLY.

Read Full Article

Delveinsight - Adrenocortical Carcinoma Market Forecast upto 2034—Insights into Emerging Therapies and Market Trends | DelveInsight

The adrenocortical carcinoma market is expected to grow from USD 30 million in 2024, driven by emerging therapies and increasing ACC cases. Key emerging treatments include CY-101 and OR-449, with several pharmaceutical companies exploring innovative approaches to treating this rare cancer.

Related tickers: GSK, BMY, CELGr, MRK.

Read Full Article

Trending Tickers

Please sign in to view